IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 39 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2013. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 4 | -99.8% | 0.00% | – |
Q3 2015 | $1,000 | -99.4% | 2,504 | -99.3% | 0.00% | – |
Q2 2015 | $173,000 | +440.6% | 367,628 | +450.0% | 0.00% | – |
Q1 2015 | $32,000 | 0.0% | 66,846 | +51.7% | 0.00% | – |
Q4 2014 | $32,000 | -77.8% | 44,064 | -72.9% | 0.00% | – |
Q3 2014 | $144,000 | -15.3% | 162,854 | +6.5% | 0.00% | – |
Q2 2014 | $170,000 | +36.0% | 152,854 | +49.1% | 0.00% | – |
Q1 2014 | $125,000 | – | 102,504 | +98461.5% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 104 | -99.7% | 0.00% | – |
Q3 2013 | $102,000 | – | 40,004 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Callan Capital, LLC | 393,912 | $351,000 | 0.10% |
Ifrah Financial Services, Inc. | 18,500 | $16,000 | 0.01% |
CHELSEA COUNSEL CO | 28,000 | $25,000 | 0.01% |
B. Riley Wealth Management, Inc. | 8,000 | $7,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 63,800 | $57,000 | 0.00% |
First Allied Advisory Services, Inc. | 45,000 | $40,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 50,124 | $45,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $62,000 | 0.00% |
Gerstein Fisher | 13,000 | $12,000 | 0.00% |
Vantage Investment Advisors, LLC | 3,000 | $3,000 | 0.00% |